Photo Credit: Nortonrsx
Systolic Blood Pressure Intervention Trial (Sprint) Results are transferrable to trial-ligable Patients with ckd in clinical practical, according to findings published in Jama Network Open. Manjula Kurella Tamura, MD, MPHand Colleagues Examined WHETHER results from sprint were transferrable to population with ckd from the veterans health administration (VHA; n = 85,938) and permanent kaiser of Southern California (KPSC; n = 13,983). Patients from the vha and kPSC were Older and Had Higher Albuminuria Than Sprint Participants (n = 9,361). The Associations of Intensive versus Standard BP Control with Major Cardiovascular Events, All-Cause Death, and Aes Were Transferrable to the Vha and KPSC Population; In One or Both, However, The Effect on Cognitive and Ckd Outcomes was not. Intensive versus Standard BP Treatment Was Associated with Lower Absolute Risks for Major Cardiovascular Events at 4 years by 5.1% and 3.0% in the vha and kPSC, respective, and with Higher risks for aes by 1.3% and 3.1% in the vha and kPSC, respective.
